News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
222,787 Results
Type
Article (4988)
Company Profile (18)
Press Release (217781)
Section
Business (82200)
Career Advice (461)
Deals (15040)
Drug Delivery (8)
Drug Development (19055)
Employer Resources (30)
FDA (3673)
Job Trends (3900)
News (120095)
Policy (7497)
Tag
Academia (290)
Alliances (14738)
Alzheimer's disease (224)
Approvals (3676)
Artificial intelligence (25)
Bankruptcy (95)
Best Places to Work (2854)
Breast cancer (38)
Cancer (331)
Career advice (391)
Cell therapy (75)
Clinical research (15851)
Collaboration (119)
Compensation (104)
COVID-19 (297)
C-suite (63)
Data (372)
Diabetes (29)
Diagnostics (2013)
Earnings (40085)
Employer resources (31)
Events (37270)
Executive appointments (211)
FDA (3837)
Funding (137)
Gene therapy (34)
GLP-1 (99)
Government (406)
Healthcare (5021)
Infectious disease (309)
Inflammatory bowel disease (23)
Interviews (53)
IPO (7777)
Job creations (1122)
Job search strategy (360)
Layoffs (97)
Legal (2326)
Lung cancer (34)
Manufacturing (38)
Medical device (3833)
Medtech (3834)
Mergers & acquisitions (7375)
Metabolic disorders (90)
Neuroscience (289)
NextGen: Class of 2025 (1672)
Non-profit (727)
Northern California (661)
Obesity (43)
Opinion (29)
People (24341)
Phase I (4732)
Phase II (6893)
Phase III (5464)
Pipeline (312)
Postmarket research (625)
Preclinical (1845)
Press Release (66)
Radiopharmaceuticals (104)
Rare diseases (54)
Real estate (1869)
Regulatory (5030)
Research institute (298)
Resumes & cover letters (68)
Southern California (499)
Startups (1007)
United States (5195)
Vaccines (27)
Date
Today (34)
Last 7 days (120)
Last 30 days (617)
Last 365 days (10875)
2025 (584)
2024 (11030)
2023 (13193)
2022 (18660)
2021 (19679)
2020 (18239)
2019 (13209)
2018 (10205)
2017 (10001)
2016 (9157)
2015 (12121)
2014 (9587)
2013 (7708)
2012 (8331)
2011 (8797)
2010 (8635)
Location
Africa (182)
Arizona (52)
Asia (11338)
Australia (1578)
California (1378)
Canada (550)
China (43)
Colorado (61)
Connecticut (72)
Europe (24159)
Florida (185)
Georgia (27)
Illinois (87)
Indiana (44)
Japan (42)
Kansas (24)
Maine (36)
Maryland (165)
Massachusetts (1143)
Michigan (73)
Minnesota (114)
New Jersey (405)
New York (361)
North Carolina (265)
Northern California (661)
Ohio (42)
Pennsylvania (265)
South America (274)
Southern California (499)
Texas (168)
Utah (41)
Virginia (28)
Washington State (119)
222,787 Results for "haemonetics corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
January 14, 2025
·
4 min read
Press Releases
Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
·
1 min read
Deals
Haemonetics Corporation Completes Acquisition of Attune Medical
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, has completed its previously announced acquisition of privately-held Chicago-based Attune Medical, the manufacturer of the ensoETM® proactive esophageal cooling device.
April 1, 2024
·
7 min read
Deals
Haemonetics Corporation Completes Acquisition of OpSens Inc.
Haemonetics Corporation has completed its previously announced acquisition of OpSens Inc.
December 12, 2023
·
8 min read
Press Releases
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025
January 9, 2025
·
1 min read
Genetown
Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device
Haemonetics Corporation, a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launched a limited market release of its new VASCADE MVP® XL mid-bore venous closure device.
June 18, 2024
·
4 min read
Press Releases
Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A
December 3, 2024
·
5 min read
Genetown
Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes
Haemonetics Corporation announced the pricing of its offering of $600,000,000 aggregate principal amount of 2.50% Convertible Senior Notes due 2029 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
May 23, 2024
·
11 min read
Business
Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
Haemonetics Corporation announced that financial results for its fourth quarter and fiscal year 2024, which ended March 30, 2024, are available on its Investor Relations website.
May 9, 2024
·
2 min read
Business
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2024 financial results at 6:00 am ET on Thursday, May 9, 2024.
April 10, 2024
·
1 min read
1 of 22,279
Next
